Skip to content
10-Q

Quarterly Report

Ardent Health, Inc. ARDT

0001628280-26-031299

← back to feed
Filed
May 6, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 1, 2026 143.35M sh
Shares Diluted Q1 2026 · Mar 31, 2026 141.78M sh
Shares Diluted Q1 2026 · Mar 31, 2025 140.7M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$60.22M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$24.79M
Long Term Debt Q1 2026 · Mar 31, 2026 $1.07B
Long Term Debt Q1 2026 · Dec 31, 2025 $1.08B
Short Term Debt Q1 2026 · Mar 31, 2026 $37.64M
Short Term Debt Q1 2026 · Dec 31, 2025 $23.44M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $609.69M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $709.6M
Stockholders Equity Q1 2026 · Mar 31, 2026 $1.34B
Stockholders Equity Q1 2026 · Dec 31, 2025 $1.29B
Current Liabilities Q1 2026 · Mar 31, 2026 $951.48M
Current Liabilities Q1 2026 · Dec 31, 2025 $1.05B
Total Liabilities Q1 2026 · Mar 31, 2026 $3.52B
Total Liabilities Q1 2026 · Dec 31, 2025 $3.61B
Current Assets Q1 2026 · Mar 31, 2026 $2.02B
Current Assets Q1 2026 · Dec 31, 2025 $2.06B
Total Assets Q1 2026 · Mar 31, 2026 $5.25B
Total Assets Q1 2026 · Dec 31, 2025 $5.29B
Eps Diluted Q1 2026 · Mar 31, 2026 $0.28
Eps Diluted Q1 2026 · Mar 31, 2025 $0.29
Eps Basic Q1 2026 · Mar 31, 2026 $0.28
Eps Basic Q1 2026 · Mar 31, 2025 $0.30
Sga Expense Q1 2026 · Mar 31, 2026 $48.6M
Sga Expense Q1 2026 · Mar 31, 2025 $34.9M
Net Income Q1 2026 · Mar 31, 2026 $39.85M
Net Income Q1 2026 · Mar 31, 2025 $41.38M
Revenue Q1 2026 · Mar 31, 2026 $1.6B
Revenue Q1 2026 · Mar 31, 2025 $1.5B